Professor
Jahangirnagar University, Dhaka, Bangladesh
Kabirul Bashar is a distinguished Medical Entomologist, Scientist, and prominent public speaker specializing in Dengue, Chikungunya, Malaria, and Filariasis in Bangladesh. He currently serves as an International Exchange Adviser and Collaborative Professor at Kanazawa University, Japan. Dr. Bashar has consulted for the WHO, the Global Fund, the National Malaria and Dengue Control Program, and numerous multinational companies. He also holds editorial board positions for several international journals.
Dr. Bashar’s research lab focuses on insect-borne disease transmission, conducting studies both in the laboratory and in the field. His research encompasses the entomology and epidemiology of mosquito-borne diseases. His work includes examining vector species compositions, vector bionomics, control strategies, intervention evaluations, vector population biology, and the intersection of human behavior and epidemiology. The primary goal is to gather evidence to enhance understanding and guide strategies and policies aimed at protecting the world’s most vulnerable populations from these diseases.
Dr. Bashar’s lab supports various national and international organizations in making evidence-driven decisions on vector control strategies. Their research helps identify gaps in current vector control interventions, understand native vector bionomics, and explore transmission drivers. This data is vital for tailoring solutions to reduce vector populations and human-vector contact, ultimately aiming for maximum impact with minimal resources.
Over the past 25 years, Dr. Bashar’s lab has conducted research in countries including Bangladesh, India, Malaysia, Thailand, Singapore, Japan, Greece, Italy, USA, and Canada. His lab studies disease transmission dynamics globally, investigating mosquito vector species, their bionomics, and the effects of human and vector behaviors on disease transmission and intervention effectiveness. Their mission is to support evidence-based decisions to protect human health.
Disclosure information not submitted.
Wednesday, March 5, 2025
8:30 AM – 8:45 AM AST